1 - 25 of 42 results for author:"Jorcano J.L." in Literature citations
Results Customize
› Repeat search in UniProtKB (13)
| Increased IKKalpha expression in the basal layer of the epidermis of transgenic mice enhances the malignant potential of skin tumors. Alameda J.P., Moreno-Maldonado R., Fernandez-Acenero M.J., Navarro M., Page A., Jorcano J.L., Bravo A., Ramirez A., Casanova M.L. PLoS ONE 6:e21984-e21984(2011) · Mapped (9) |
| Development of a bioengineered skin-humanized mouse model for psoriasis: dissecting epidermal-lymphocyte interacting pathways. Guerrero-Aspizua S., Garcia M., Murillas R., Retamosa L., Illera N., Duarte B., Holguin A., Puig S., Hernandez M.I., Meana A. et al. Am. J. Pathol. 177:3112-3124(2010) · Mapped (3) |
| An inactivating CYLD mutation promotes skin tumor progression by conferring enhanced proliferative, survival and angiogenic properties to epidermal cancer cells. Alameda J.P., Moreno-Maldonado R., Navarro M., Bravo A., Ramirez A., Page A., Jorcano J.L., Fernandez-Acenero M.J., Casanova M.L. Oncogene 29:6522-6532(2010) · Mapped (5) |
| IKKbeta leads to an inflammatory skin disease resembling interface dermatitis. Page A., Navarro M., Garin M., Perez P., Casanova M.L., Moreno R., Jorcano J.L., Cascallana J.L., Bravo A., Ramirez A. J. Invest. Dermatol. 130:1598-1610(2010) · Mapped (7) |
| The first COL7A1 mutation survey in a large Spanish dystrophic epidermolysis bullosa cohort: c.6527insC disclosed as an unusually recurrent mutation. Escamez M.J., Garcia M., Cuadrado-Corrales N., Llames S.G., Charlesworth A., De Luca N., Illera N., Sanchez-Jimeno C., Holguin A., Duarte B. et al. Br. J. Dermatol. 163:155-161(2010) · Mapped (2) |
| Keratinocyte-derived follistatin regulates epidermal homeostasis and wound repair. Antsiferova M., Klatte J.E., Bodo E., Paus R., Jorcano J.L., Matzuk M.M., Werner S., Kogel H. Lab. Invest. 89:131-141(2009) · Mapped (2) |
| IKKalpha enhances human keratinocyte differentiation and determines the histological variant of epidermal squamous cell carcinomas. Moreno-Maldonado R., Ramirez A., Navarro M., Fernandez-Acenero M.J., Villanueva C., Page A., Jorcano J.L., Bravo A., Llanos Casanova M. Cell Cycle 7:2021-2029(2008) · Mapped (12) |
| In vitro and in vivo wound healing-promoting activities of human cathelicidin LL-37. Carretero M., Escamez M.J., Garcia M., Duarte B., Holguin A., Retamosa L., Jorcano J.L., Rio M.D., Larcher F. J. Invest. Dermatol. 128:223-236(2008) · Mapped (2) |
| Epidermal hyperplasia and papillomatosis in mice with a keratinocyte-restricted deletion of csk. Honda K., Sakaguchi T., Sakai K., Schmedt C., Ramirez A., Jorcano J.L., Tarakhovsky A., Kamisoyama H., Sakai T. Carcinogenesis 28:2074-2081(2007) · Mapped (3) |
| Hair cycle and wound healing in mice with a keratinocyte-restricted deletion of FAK. Essayem S., Kovacic-Milivojevic B., Baumbusch C., McDonagh S., Dolganov G., Howerton K., Larocque N., Mauro T., Ramirez A., Ramos D.M. et al. Oncogene 25:1081-1089(2006) · Mapped (11) |
| Conditional ablation of C/EBP beta demonstrates its keratinocyte-specific requirement for cell survival and mouse skin tumorigenesis. Sterneck E., Zhu S., Ramirez A., Jorcano J.L., Smart R.C. Oncogene 25:1272-1276(2006) · Mapped (3) |
| Targeted overexpression of leptin to keratinocytes in transgenic mice results in lack of skin phenotype but induction of early leptin resistance. Rico L., Del Rio M., Bravo A., Ramirez A., Jorcano J.L., Page M.A., Larcher F. Endocrinology 146:4167-4176(2005) · Mapped (4) |
| Ectoderm-targeted overexpression of the glucocorticoid receptor induces hypohidrotic ectodermal dysplasia. Cascallana J.L., Bravo A., Donet E., Leis H., Lara M.F., Paramio J.M., Jorcano J.L., Perez P. Endocrinology 146:2629-2638(2005) · Mapped (66) |
| Epidermal abnormalities and increased malignancy of skin tumors in human epidermal keratin 8-expressing transgenic mice. Casanova M.L., Bravo A., Martinez-Palacio J., Fernandez-Acenero M.J., Villanueva C., Larcher F., Conti C.J., Jorcano J.L. FASEB J. 18:1556-1558(2004) · Mapped (3) |
| Unique and overlapping functions of pRb and p107 in the control of proliferation and differentiation in epidermis. Ruiz S., Santos M., Segrelles C., Leis H., Jorcano J.L., Berns A., Paramio J.M., Vooijs M. Development 131:2737-2748(2004) · Mapped (12) |
| A keratin K5Cre transgenic line appropriate for tissue-specific or generalized Cre-mediated recombination. Ramirez A., Page A., Gandarillas A., Zanet J., Pibre S., Vidal M., Tusell L., Genesca A., Whitaker D.A., Melton D.W. et al. Genesis 39:52-57(2004) · Mapped (6) |
| Glucocorticoid Receptor Counteracts Tumorigenic Activity of Akt in Skin through Interference with the Phosphatidylinositol 3-Kinase Signaling Pathway. Leis H., Page A., Ramirez A., Bravo A., Segrelles C., Paramio J., Barettino D., Jorcano J.L., Perez P. Mol. Endocrinol. 18:303-311(2004) · Mapped (12) |
| Tumor formation in mice with conditional inactivation of Brca1 in epithelial tissues. Berton T.R., Matsumoto T., Page A., Conti C.J., Deng C.X., Jorcano J.L., Johnson D.G. Oncogene 22:5415-5426(2003) · Mapped (7) |
| Modulation of the angiogenesis response through Ha-ras control, placenta growth factor, and angiopoietin expression in mouse skin carcinogenesis. Larcher F., Franco M., Bolontrade M., Rodriguez-Puebla M., Casanova L., Navarro M., Yancopoulos G., Jorcano J.L., Conti C.J. Mol. Carcinog. 37:83-90(2003) · Mapped (12) |
| Abnormal epidermal differentiation and impaired epithelial-mesenchymal tissue interactions in mice lacking the retinoblastoma relatives p107 and p130. Ruiz S., Segrelles C., Bravo A., Santos M., Perez P., Leis H., Jorcano J.L., Paramio J.M. Development 130:2341-2353(2003) · Mapped (78) |
| Disruption of eyelid and cornea development by targeted overexpression of the glucocorticoid receptor. Cascallana J.L., Bravo A., Page A., Budunova I., Slaga T.J., Jorcano J.L., Perez P. Int. J. Dev. Biol. 47:59-64(2003) · Mapped (18) |
| Impaired NF-kappa B activation and increased production of tumor necrosis factor alpha in transgenic mice expressing keratin K10 in the basal layer of the epidermis. Santos M., Perez P., Segrelles C., Ruiz S., Jorcano J.L., Paramio J.M. J. Biol. Chem. 278:13422-13430(2003) · Mapped (5) |
| Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors. Casanova M.L., Blazquez C., Martinez-Palacio J., Villanueva C., Fernandez-Acenero M.J., Huffman J.W., Jorcano J.L., Guzman M. J. Clin. Invest. 111:43-50(2003) · UniProtKB (2) · Mapped (3) |
| Abnormal cochlea linked to deafness in transgenic mice expressing human cytokeratin K8. Bartolome M.V., Casanova M.L., Carricondo F., del Castillo E., Jorcano J.L., Gil-Loyzaga P. Histol. Histopathol. 17:827-836(2002) · Mapped (5) |
| Severe abnormalities in the oral mucosa induced by suprabasal expression of epidermal keratin K10 in transgenic mice. Santos M., Bravo A., Lopez C., Paramio J.M., Jorcano J.L. J. Biol. Chem. 277:35371-35377(2002) · Mapped (2) |